ŞANLIOĞLU, S. Et Al. 2008. Pancreatic ductal adenocarcinoma (PDAC) patients displayed high levels of TRAIL death receptor-4 (DR4) and decoy receptor-2 (DCR2) expressions in connection with significant amount of cell death.. 3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi , (İstanbul, Turkey), 6.

ŞANLIOĞLU, S., ŞANLIOĞLU, A. D., KORCUM ŞAHİN, A. F., Dirice, E., ELPEK, G. Ö., SÜLEYMANLAR, İ., ... ÖZDOĞAN, M.(2008). Pancreatic ductal adenocarcinoma (PDAC) patients displayed high levels of TRAIL death receptor-4 (DR4) and decoy receptor-2 (DCR2) expressions in connection with significant amount of cell death. . 3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi (pp.6). İstanbul, Turkey

ŞANLIOĞLU, SALİH Et Al. "Pancreatic ductal adenocarcinoma (PDAC) patients displayed high levels of TRAIL death receptor-4 (DR4) and decoy receptor-2 (DCR2) expressions in connection with significant amount of cell death.," 3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Turkey, 2008

ŞANLIOĞLU, SALİH Et Al. "Pancreatic ductal adenocarcinoma (PDAC) patients displayed high levels of TRAIL death receptor-4 (DR4) and decoy receptor-2 (DCR2) expressions in connection with significant amount of cell death.." 3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi , İstanbul, Turkey, pp.6, 2008

ŞANLIOĞLU, S. Et Al. (2008) . "Pancreatic ductal adenocarcinoma (PDAC) patients displayed high levels of TRAIL death receptor-4 (DR4) and decoy receptor-2 (DCR2) expressions in connection with significant amount of cell death.." 3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi , İstanbul, Turkey, p.6.

@conferencepaper{conferencepaper, author={SALİH ŞANLIOĞLU Et Al. }, title={Pancreatic ductal adenocarcinoma (PDAC) patients displayed high levels of TRAIL death receptor-4 (DR4) and decoy receptor-2 (DCR2) expressions in connection with significant amount of cell death.}, congress name={3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi}, city={İstanbul}, country={Turkey}, year={2008}, pages={6} }